List of Excipients in API sodium phenylbutyrate/taurursodiol
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing sodium phenylbutyrate/taurursodiol
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Amylyx Pharmaceuticals Inc | RELYVRIO | sodium phenylbutyrate/taurursodiol | 73063-035 | ACACIA | 2029-09-29 |
| Amylyx Pharmaceuticals Inc | RELYVRIO | sodium phenylbutyrate/taurursodiol | 73063-035 | DEXTRATES | 2029-09-29 |
| Amylyx Pharmaceuticals Inc | RELYVRIO | sodium phenylbutyrate/taurursodiol | 73063-035 | MALTODEXTRIN | 2029-09-29 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for sodium phenylbutyrate/taurursodiol
Excipient focus: ACACIA
sodium phenylbutyrate/taurursodiol drug variants containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
| >Company | >Ingredient | >NDC |
sodium phenylbutyrate/taurursodiol drug variants not containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: DEXTRATES
sodium phenylbutyrate/taurursodiol drug variants containing DEXTRATES
| Company | Ingredient | NDC |
|---|---|---|
| Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
| >Company | >Ingredient | >NDC |
sodium phenylbutyrate/taurursodiol drug variants not containing DEXTRATES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
sodium phenylbutyrate/taurursodiol drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
| >Company | >Ingredient | >NDC |
sodium phenylbutyrate/taurursodiol drug variants not containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
sodium phenylbutyrate/taurursodiol drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
| >Company | >Ingredient | >NDC |
sodium phenylbutyrate/taurursodiol drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
sodium phenylbutyrate/taurursodiol drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
| >Company | >Ingredient | >NDC |
sodium phenylbutyrate/taurursodiol drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
sodium phenylbutyrate/taurursodiol drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
| >Company | >Ingredient | >NDC |
sodium phenylbutyrate/taurursodiol drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
sodium phenylbutyrate/taurursodiol drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
| >Company | >Ingredient | >NDC |
sodium phenylbutyrate/taurursodiol drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
sodium phenylbutyrate/taurursodiol drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
| >Company | >Ingredient | >NDC |
sodium phenylbutyrate/taurursodiol drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
sodium phenylbutyrate/taurursodiol drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
| >Company | >Ingredient | >NDC |
sodium phenylbutyrate/taurursodiol drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
